IFF fragrance sales down
This article was originally published in The Rose Sheet
Executive Summary
New York-based International Flavors & Fragrances reports sales decline of 8% for its fragrance division in fiscal 2009, as a result of retail consumption declines and supply chain contraction. Cost controls helped the firm build sales and earnings momentum in the second half of the year, Kevin Berryman, executive vice president and CFO, notes. Fourth-quarter sales were up 9% overall (up 2% excluding the impact of foreign currency) to $586 mil., while full-year sales dipped 3% to $2.3 bil. Earnings were down 3% in the fourth quarter to $47.4 mil. and fell 15% for the full year to $195.5 mil., impacted by restructuring charges, employee separation costs and tax benefits in the year prior, according to Feb. 9 announcement
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.